These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 33188277)

  • 1. Pulmonary fibrosis in critically ill patients with novel coronavirus pneumonia during the convalescent stage and a proposal for early intervention.
    Zou H; Li SQ
    Acta Pharmacol Sin; 2021 Aug; 42(8):1376-1378. PubMed ID: 33188277
    [No Abstract]   [Full Text] [Related]  

  • 2. Discharge may not be the end of treatment: Pay attention to pulmonary fibrosis caused by severe COVID-19.
    Zhang C; Wu Z; Li JW; Tan K; Yang W; Zhao H; Wang GQ
    J Med Virol; 2021 Mar; 93(3):1378-1386. PubMed ID: 33107641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pulmonary fibrosis].
    Gómez Carrera L; Álvarez-Sala Walther R
    Med Clin (Barc); 2016 Feb; 146(3):115-6. PubMed ID: 26238516
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-related fibrosis: insights into potential drug targets.
    Sgalla G; Comes A; Lerede M; Richeldi L
    Expert Opin Investig Drugs; 2021 Dec; 30(12):1183-1195. PubMed ID: 34842488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolving pharmacotherapy of pulmonary fibrosis.
    Lota HK; Wells AU
    Expert Opin Pharmacother; 2013 Jan; 14(1):79-89. PubMed ID: 23265249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2 : Anti-inflammatory and anti-fibrotic therapy could solve the lung complications of the infection?
    Ferrara F; Granata G; Pelliccia C; La Porta R; Vitiello A
    Eur J Clin Pharmacol; 2020 Nov; 76(11):1615-1618. PubMed ID: 32594204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae?
    Bari E; Ferrarotti I; Saracino L; Perteghella S; Torre ML; Richeldi L; Corsico AG
    Cells; 2021 May; 10(5):. PubMed ID: 34068958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dapsone and doxycycline could be potential treatment modalities for COVID-19.
    Farouk A; Salman S
    Med Hypotheses; 2020 Jul; 140():109768. PubMed ID: 32339778
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of anticoagulant therapy on the course of COVID-19 in comorbid patients].
    Ruzhentsova TA; Khavkina DA; Chukhliaev PV; Garbuzov AA; Ploskireva AA
    Vopr Virusol; 2021 Mar; 66(1):40-46. PubMed ID: 33683064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
    Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
    JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylcysteine as a therapeutic approach to post-COVID-19 pulmonary fibrosis adjunctive treatment.
    Micheletto C; Izquierdo JL; Avdeev SN; Rada Escobar RA; Pacheco Gallego MC
    Eur Rev Med Pharmacol Sci; 2022 Jul; 26(13):4872-4880. PubMed ID: 35856379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Efficacy of Convalescent Plasma Use in Critically Ill COVID-19 Patients.
    Tirnea L; Bratosin F; Vidican I; Cerbu B; Turaiche M; Timircan M; Margan MM; Marincu I
    Medicina (Kaunas); 2021 Mar; 57(3):. PubMed ID: 33799535
    [No Abstract]   [Full Text] [Related]  

  • 13. Hot off the breath: A big step forward for idiopathic pulmonary fibrosis.
    Ryerson CJ; Collard HR
    Thorax; 2014 Sep; 69(9):791-2. PubMed ID: 24996636
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis arising as a sequelae in convalescent COVID-19 patients: a randomized multicenter trial.
    Lu ZH; Yang CL; Yang GG; Pan WX; Tian LG; Zheng JX; Lv S; Zhang SY; Zheng PY; Zhang SX
    Infect Dis Poverty; 2021 Mar; 10(1):31. PubMed ID: 33731163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of pulmonary fibrosis in one convalescent patient with corona virus disease 2019 by oral traditional Chinese medicine decoction: A case report.
    Zhi N; Mo Q; Yang S; Qin YX; Chen H; Wu ZG; Lan CH; Zhang J; Li YL
    J Integr Med; 2021 Mar; 19(2):185-190. PubMed ID: 33349611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.
    Les Bujanda I; Loureiro-Amigo J; Bastons FC; Guerra IE; Sánchez JA; Murgadella-Sancho A; Rey RG; López JL; Álvarez JS
    Trials; 2021 Jan; 22(1):43. PubMed ID: 33430891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How to face the current status of therapies for idiopathic pulmonary fibrosis].
    Zhang DP
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Nov; 36(11):844-7. PubMed ID: 24507398
    [No Abstract]   [Full Text] [Related]  

  • 18. INFUSION OF CONVALESCENT PLASMA IS ASSOCIATED WITH CLINICAL IMPROVEMENT IN CRITICALLY ILL PATIENTS WITH COVID-19: A PILOT STUDY.
    Olivares-Gazca JC; Priesca-Marín JM; Ojeda-Laguna M; Garces-Eisele J; Soto-Olvera S; Palacios-Alonso A; Izquierdo-Vega J; Chacon-Cano R; Arizpe-Bravo D; López-Trujillo MA; Cantero-Fortiz Y; Fernandez-Lara D; Ruiz-Delgado GJ; Ruiz-Argüelles GJ
    Rev Invest Clin; 2020; 72(3):159-164. PubMed ID: 32584322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antifibrotic therapy and progressive lung fibrosis].
    Fellrath JM
    Rev Med Suisse; 2020 Jun; 16(698):1256-1260. PubMed ID: 32558455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
    Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
    Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.